Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Pilot Study of the Efficacy and Safety of Using Hemoperfusion With Efferon CT to Treat Patients With Severe Psoriasis

NCT06640114 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.

NCT NCT06640114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06640114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Pilot Study of the Efficacy and Safety of Using Hemoperfusion With Efferon CT to Treat Patients With Severe Psoriasis
Lead sponsor
Efferon JSC
Phase
Not applicable
Overall status
Completed
Start date
October 22, 2024
Completion date
July 14, 2025
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis